Previous Page  20 / 65 Next Page
Information
Show Menu
Previous Page 20 / 65 Next Page
Page Background

Page 40

May 24-25, 2018

London, UK

Vascular Surgery 2018

3

rd

Edition of World Congress & Exhibition on

Vascular Surgery

Journal of Vascular and Endovascular Therapy

ISSN: 2573-4482

Aim:

We aimed to evaluate short and mid-term results of

commercially available prefabricated vascular grafts made

of bovine pericardium. Herein, we report on our institutional

experience with the use of these grafts.

Methods:

Six patients underwent Aorto- Iliac repair with

commercially available graftsmade of bovine pericardium (BPG),

in an additional patient a BPG was utilized for the management

of an infected PTFE fem-pop bypass graft, for the management

of graft infection or in the presence of systemic infection.

Comorbidities, procedure related details, postoperative mortality

and mid-term follow up were assessed and analyzed. The seven

patients treated with BPGs form the base of this study.

Results:

71% (5) were male, mean age was 61.4±10.9 years.

Comorbidities: arterial hypertension 100% (7), smoking 71% (5),

coronary artery disease 43% (3), peripheral arterial disease 86%

(6) and chronic renal disease 29% (2). Indications for surgery

were: i) graft infection 71% (5), ii) arterial reconstruction in the

presence of systemic infection 29% (2). Five patients (71%) had

a history of previous vascular surgery. In 86%, polymicrobial

cultures were available (6), amongst the isolated pathogens

were Staph aureus, Pseudomonas aeruginosa and E. coli. For

direct repair a bifurcated graft configuration was used in all

aortic cases. Median follow-up: 107 days (max: seven months).

Thirty-day mortality was 14% (1) – congestive heart failure – a

patient operated successfully for an infected graft, undergoing

surgery for control of infection prior to intended cardiac surgery,

overall mortality was 14%.

Conclusion:

Our data support the conclusion that the use of

BPGs represents an excellent conduit for the management of:

i) aortic graft infections, ii) aortic reconstruction in the presence

of systemic infection, and iii) infected prosthetic grafts utilized

in peripheral arterial reconstructive surgery.

Recent Publications

1. Piechota Polanczyk A, Demyanets S, Mittlboeck M,

Hofmann M, Domenig C M, Neumayer C, Wojta J, Klinger

M, Nanobachvili J and Huk I (2015) The influence of

simvastatin on NGAL, matrix metalloproteinases and

their tissue inhibitors in human intraluminal thrombus

andabdominal aortic aneurysmtissue. EuropeanJournal

of Vascular and Endovascular Surgery 49(5):549-55.

2. Fokkema M, Vrijenhoek J E, Den Ruijter H M, Groenwold

R H, Schermerhorn M L, Bots M L, Pasterkamp G, Moll

F L and De Borst G J; TREAT CARE study group (2015)

Stenting versus endarterectomy for restenosis following

prior ipsilateral carotid endarterectomy: an individual

patient data meta-analysis. Ann Surg. 261(3):598-604.

3. Domenig C Linni K, Mader N, Kretschmer G,

Magometschnigg H and Hölzenbein T J (2008)

Subclavian to carotid artery transposition: medial

versus lateral approach. European Journal of Vascular

and Endovascular Surgery 35(5):551-7.

4. Kinstner C, Teufelsbauer H, Neumayer C, Domenig

C, Wressnegger A, Wolf F and Funovics M (2014)

Endovascular repair of thoracoabdominal aortic

aneurysms with a novel multibranch stent-graft design:

preliminary experience. Journal of Vascular Surgery

(Torino) 55(4):543-50.

5. PiechotaPolanczykA,GoracaA,DemyanetsS,Mittlboeck

M, Domenig C, Neumayer C, Wojta J, Nanobachvili J,

Huk I and Klinger M (2012) Simvastatin decreases

free radicals formation in the human abdominal aortic

aneurysm wall via NF-κB. European Journal of Vascular

and Endovascular Surgery 44(2):133-7

Biography

Ihor Huk is the Chairman of Division of Vascular Surgery since 2013 and

Director of Vascular Laboratory since 1994, Department of Surgery Medical

Bovine pericardial grafts for the management of aortic graft

infections: single center experience

Ihor Huk, Christoph M Domenig, Markus Klinger, Christopher Burghuber, Wolf

Eilenberg, Christoph Neumayer

and

Josif Nanobachvili

Medical University of Vienna, Austria

Ihor Huk et al., J Vasc Endovasc Therapy 2018, Volume 3

DOI: 10.21767/2573-4482-C1-002